Detalles de la búsqueda
1.
Management, risk factors and prognostic impact of checkpoint-inhibitor pneumonitis (CIP) in lung cancer - A multicenter observational analysis.
Lung Cancer
; 179: 107184, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37040677
2.
Recurrence patterns and impact of brain metastases in synchronous single organ oligometastatic lung cancer following local ablative treatment - A multicenter analysis.
Lung Cancer
; 170: 165-175, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35803041
3.
Pembrolizumab as First-Line Palliative Therapy in PD-L1 Overexpressing (≥ 50%) NSCLC: Real-world Results with Special Focus on PS ≥ 2, Brain Metastases, and Steroids.
Clin Lung Cancer
; 22(5): 411-422, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33648877
4.
KRASG12C/TP53 co-mutations identify long-term responders to first line palliative treatment with pembrolizumab monotherapy in PD-L1 high (≥50%) lung adenocarcinoma.
Transl Lung Cancer Res
; 10(2): 737-752, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33718018
Resultados
1 -
4
de 4
1
Próxima >
>>